source
- Former FDA official says leadership turnover won’t derail push for faster US drug trialsThe Food and Drug Administration has faced a wave of leadership changes this year, creating uncertainty about its ability to keep drug development moving quickly. Industry leaders and regulators, h…
- GSK and Ionis report functional cure in 20% of hepatitis B patients with bepirovirsen in early trialsGSK and Ionis disclosed results from two clinical studies of their RNA‑based injection, bepirovirsen, aimed at achieving a functional cure for chronic hepatitis B. In both trials about one‑fifth o…